FDA recall record

Ondansetron Injection, USP, 4 mg/2 mL (2 mg/mL), 2 mL per vial recall — FDA D-0146-2024

Failed pH Specifications

Class IIclassification
D-0146-2024official record ID
Dec 13, 2023report date

Recall record at a glance

Official recordD-0146-2024
CategoryDrug Recalls
ClassificationClass II
FDA record statusCompleted
Recalling firmBaxter Healthcare Corporation
Report dateDec 13, 2023
Recall initiation dateNov 14, 2023
Quantity6,022,675 vials
LocationDeerfield, IL, United States

Official product description

Ondansetron Injection, USP, 4 mg/2 mL (2 mg/mL), 2 mL per vial, Rx only, Manufactured for: Baxter Healthcare Corporation, Deerfield, IL 60015 USA. Manufactured by: Baxter Pharmaceuticals India Private Ltd, Ahmedabad 382213, India. NDC 36000-012-25

Why the product was recalled

Failed pH Specifications

Distribution information

Nationwide in the USA

How to read the classification

FDA Class II indicates a situation in which use of or exposure to the product may cause temporary or medically reversible adverse health consequences, or where the probability of serious consequences is remote. The classification shown here comes from the FDA record.

Additional record details

Recall type: Voluntary: Firm initiated. Initial notification: Letter.

What to do next

If you believe you have the recalled product, use the recall number and firm information above to confirm the official notice and follow the instructions issued by the FDA, recalling firm, retailer or product manufacturer. For drugs and medical devices, decisions about treatment or medical care should be discussed with a qualified health professional.

About this record

Recall Lookup USA preserves the most complete source information successfully retrieved. We do not create missing facts or infer affected lots or VINs. The official record may still change, so use the identifier above when verifying current instructions.

FDA source limitation: openFDA enforcement reports are a reference dataset, not a live public-alert or recall-lifecycle service. FDA notes that enforcement-report status may not be updated after classification. Confirm current actions with the FDA, recalling firm or appropriate healthcare professional when relevant.

Related recall records

Other records from the same recalling company are shown first when available.

Medical DeviceJun 10, 2026

Exacta Mix Vented Micro-Volume Inlet recall — FDA Z-2262-2026

Affected lots may contain incorrect 0.8-micron filters. Use of a 0.8-micron filter in place of the validated 3-micron filter may lead to reduced flow efficiency, incomplete or slower…

Class IIFDA: OngoingBaxter Healthcare Corporation